Barker, S D <br/><br/>
Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.  [electronic resource] 

 -  Gene therapy  Jul 2003 
 - 1198-204 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0969-7128 
<br/><br/><label>Standard No.: </label>10.1038/sj.gt.3301974  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--therapy<br/>Adenoviridae--genetics<br/>Animals<br/>Antibodies--genetics<br/>Cytomegalovirus--genetics<br/>Female<br/>Gene Expression<br/>Gene Targeting--methods<br/>Genetic Therapy--methods<br/>Genetic Vectors--administration & dosage<br/>Humans<br/>Liver--enzymology<br/>Luciferases--analysis<br/>Mice<br/>Mice, SCID<br/>Models, Animal<br/>Ovarian Neoplasms--therapy<br/>Promoter Regions, Genetic<br/>Proteinase Inhibitory Proteins, Secretory<br/>Proteins--genetics<br/>Receptor, ErbB-2--immunology<br/>Secretory Leukocyte Peptidase Inhibitor<br/>Transcription, Genetic<br/>Transduction, Genetic--methods<br/>Tumor Cells, Cultured